DRD Biotech is a diagnostic company based in the Republic of Buryatia, Russia. Since its establishment in 2014, the company has been at the forefront of developing and implementing diagnostic devices that use innovative bio- and IT-technologies. They specialize in creating rapid blood tests for healthcare, with a focus on diagnosing brain damage such as Ischemic Stroke and Traumatic Brain Injury.

One of their notable products is the NR2 antibodies, which serve as a biomarker for cerebral ischemia. Studies have shown that high blood concentrations of antibodies to NR2 indicate an increased risk of ischemic stroke. Additionally, these antibodies can also predict the development of transient ischemic attacks.

DRD Biotech collaborates with research centers and medical companies from Russia, the USA, and Europe, ensuring that their products are developed and manufactured to the highest standards. To learn more about their products and services, you can visit their website or get in touch with them via their contact details provided. With a commitment to affordable and reliable rapid diagnostics, DRD Biotech is dedicated to making a positive impact on the field of diagnostics in Russia and beyond